We found that eliminating both VEGF-B and IL-17A significantly ameliorated renal dysfunction and disease progression in DKD mice by reducing the ectopic lipid deposition, and inflammation and inhibiting the renal fibrosis response. This evidence concerns the gene IL17A and diabetic kidney disease.